Toni Giordano

MD, PhD, MSc. Digestive diseases. Amo la ciencia, la buena comida y la compañía.

[Toni Giordano @giordantoni]

We’ve been told for years that upper GI Crohn’s disease may represent a more aggressive phenotype…

But does it actually change therapeutic outcomes?

Our ENEIDA study may challenge some assumptions.

See you at our oral presentation at #UEGWeek2026 in #Barcelona.
#IBD #GETECCU

[Beatriz Gros @Bealoquebea]

The Young Group of @geteccu is that place where you grow, you learn, share, and get inspired by incredible people, always feeling supported and never alone. It promotes education & excellence in IBD at every stage, but what truly stands out is the people, the support, the closeness, and that feeling of being a small family

[Toni Giordano @giordantoni]

Jornada de Patología Digestiva con Médicos de Atención Primaria @HospitalSantPau

[Toni Giordano @giordantoni]

It was a unique privilege to attend the IBD Xcelerator Initiative during UEG Week. Excellent mentors and inspiring discussion with Prof. D’Haens. And truly superbe colleagues.

[Toni Giordano @giordantoni]

Chlamydia trachomatis 🦠
Not just an STI in men.
It can hit the rectum, cause inflammation… and even look like cancer.
Are you screening for it?
https://t.co/AzuFoqvZTP

[Iago Rodriguez-Lago @Iagorlago]

Con la presentación de Antonio Giordano da comienzo la reunión de investigación de @geteccu en #GETECCU25

[Sant Pau - Campus Salut Barcelona @HospitalSantPau]

🔸 Què sentiries si només tinguessis 5 minuts per trobar un lavabo?

El passat divendres, a #SantPau, diversos professionals del Servei de Patologia Digestiva van participar en la recreació d'una urgència per entendre millor què són les malalties inflamatòries intestinals.

🔍 Només 3 de cada 10 persones a Catalunya identifiquen la urgència d’anar al bany com un dels símptomes que més impacten la qualitat de vida de les persones amb Malaltia Inflamatòria Intestinal (MII).

Aquesta urgència, sovint invisible, pot provocar ansietat, aïllament i dificultats per participar en activitats quotidianes.

🧩 Per fer visible aquesta realitat, a #SantPau hem acollit l’”Urgency Room”, el primer escape room pensat per posar-te, literalment, a la pell de qui viu amb MII. Una experiència immersiva que reprodueix la pressió de trobar un lavabo en menys de 5 minuts.

📊 Sabies que només el 3% de la població catalana sap realment què és la MII? Iniciatives com aquesta ens ajuden a combatre el desconeixement i a fomentar la comprensió social.

💬 Entendre la malaltia és el primer pas per acompanyar millor.

#MésEmpatia

[Toni Giordano @giordantoni]

AI is revolutionizing capsule endoscopy — and it’s just getting started.

• 🩸 Spot intestinal bleeding fast
• 🔄 Speed up SB Crohn’s assessment
• 🧠 Help detect colon polyps

@DDS_Journal https://t.co/uUaHRjEVyF @Bglezsuarez @CharlyGuarner @CristinaiauHo

[Toni Giordano @giordantoni]

In Crohn’s disease, multiple interacting factors shape its clinical manifestations and long-term course. This article published in @gastroHepato offers a brief overview. @geteccu

https://t.co/2PGIg5gua6

[Toni Giordano @giordantoni]

Dr. González & the ENEIDA group of @geteccu on @JCM_MDPI:
Paediatric-onset familial IBD and disease management:
🟰 use of biologics, immunosuppressants, intestinal surgery
🔝use of perianal surgery
Family history matters—just not how you’d expect. https://t.co/T5ob9qRCUY

[Shomron Ben-Horin @ShomronH]

Our talented @Adam_goldman_ found increased intest perforations with JAKi class. Examined in Rheum pts to reduce confounding by IBD.
Caveat of voluntary reporting,but this is how aTNF TB risk was first found, so cant be lightly discarded. @UEGJournal
https://t.co/ey5Ww45Uee

[Toni Giordano @giordantoni]

New in @AmJGastro: Our @geteccu ENEIDA study provides the first conclusive evidence that Crohn’s disease with predominant ileal/ileocolonic involvement requires greater therapeutic effort and is linked to more complex disease management. Read more: https://t.co/Rad1UjgQUq

[Toni Giordano @giordantoni]

@CharlyGuarner @SEEDendoscopia @HospitalSantPau @patri_pedregal @GreenEndoscopy Enhorabuena!!

[Azucena Salas @AzucenaSalas17]

What happens to intestinal cells when patients are treated with tofacitinib? Why do responses vary between patients? Check out a new preprint from our lab for some responses @ibd_bcn @ibdleuven #IBD #scRNAseq https://t.co/F9YpfP27Kf

[Toni Giordano @giordantoni]

@Bglezsuarez @my_ueg @CrisCarretero2 @gasclinicbcn @SEEDendoscopia Congrats!!!

[Toni Giordano @giordantoni]

Muchas gracias al comité científico de @geteccu por otorgarme la beca para realizar el estudio #BAMBIE. Asumo con seriedad la responsabilidad de llevarlo a cabo con rigor y un rumbo claro. @IRSantPau

[GETECCU @geteccu]

#GETECCU24 | Las becas GETECCU de esta año recaen en:

🗣️ Héctor Rodríguez
🗣️Beatriz Mateos
🗣️Luis Fernández
🗣️Urko Martínez
🗣️Mª José Casanova
🗣️Federico Argüelles
🗣️Cristina Suárez
🗣️Antonio Giordano
🗣️ Mariam Aguas

[Shomron Ben-Horin @ShomronH]

FCP is better for colonic > small bowel (SB) inflammatiin, but how accurate is it in proximal vs. distal SB?
Using VCE as gold standard, our
@sheba_medical brilliant fellow @OffirU reports in @JCC_IBD a dilutional gradient of calpro along the SB !
https://t.co/1bizDkwNaG

[Cláudia Rodrigues @claudia_msr]

I’m very happy and proud to announce the publication of my debut as co-first-author research article in @NatImmunol ! 🎉 we revealed a distinct serum ASCA IgG glycoform able to predict the development of Crohn’s
@Salome_S_Pinho @gaifem_joana @i3S_UPorto

https://t.co/YT84DfGUXg

[Toni Giordano @giordantoni]

🔬🚀 Discover the revival of motorized spiral enteroscopy! Our study in @SciReports explores its innovative applications and clinical benefits, offering key insights for future research. #Endoscopy @Bglezsuarez @CrisCarretero2 @alonso_noe84 @lucomca https://t.co/wd8phBMM7u